BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 17316431)

  • 21. Long-term Cost-effectiveness of Statin Treatment for Primary Prevention of Cardiovascular Disease in the Elderly.
    Lin L; Teng M; Zhao YJ; Khoo AL; Seet RC; Yong QW; Yeo TC; Lim BP
    Cardiovasc Drugs Ther; 2015 Apr; 29(2):187-97. PubMed ID: 25860556
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cost-effectiveness of a fixed-dose combination pill for secondary prevention of cardiovascular disease in China, India, Mexico, Nigeria, and South Africa: a modelling study.
    Lin JK; Moran AE; Bibbins-Domingo K; Falase B; Pedroza Tobias A; Mandke CN; Kazi DS
    Lancet Glob Health; 2019 Oct; 7(10):e1346-e1358. PubMed ID: 31477544
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cost Effectiveness of Implementing Integrated Management of Neonatal and Childhood Illnesses Program in District Faridabad, India.
    Prinja S; Bahuguna P; Mohan P; Mazumder S; Taneja S; Bhandari N; van den Hombergh H; Kumar R
    PLoS One; 2016; 11(1):e0145043. PubMed ID: 26727369
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cost-effectiveness of live oral attenuated human rotavirus vaccine in Tanzania.
    Ruhago GM; Ngalesoni FN; Robberstad B; Norheim OF
    Cost Eff Resour Alloc; 2015; 13():7. PubMed ID: 25949216
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cost effectiveness of a government supported policy strategy to decrease sodium intake: global analysis across 183 nations.
    Webb M; Fahimi S; Singh GM; Khatibzadeh S; Micha R; Powles J; Mozaffarian D
    BMJ; 2017 Jan; 356():i6699. PubMed ID: 28073749
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cost-effectiveness of treating multidrug-resistant tuberculosis in treatment initiative centers and treatment follow-up centers in Ethiopia.
    Alemayehu S; Yigezu A; Hailemariam D; Hailu A
    PLoS One; 2020; 15(7):e0235820. PubMed ID: 32716915
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cost-utility analysis of antihypertensive medications in Nigeria: a decision analysis.
    Ekwunife OI; Okafor CE; Ezenduka CC; Udeogaranya PO
    Cost Eff Resour Alloc; 2013 Jan; 11(1):2. PubMed ID: 23343250
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cost, affordability and cost-effectiveness of strategies to control tuberculosis in countries with high HIV prevalence.
    Currie CS; Floyd K; Williams BG; Dye C
    BMC Public Health; 2005 Dec; 5():130. PubMed ID: 16343345
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cost-effectiveness analysis of an additional birth dose of Hepatitis B vaccine to prevent perinatal transmission in a medical setting in Mozambique.
    Klingler C; Thoumi AI; Mrithinjayam VS
    Vaccine; 2012 Dec; 31(1):252-9. PubMed ID: 22902676
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The cost-effectiveness of antiretroviral treatment in Khayelitsha, South Africa--a primary data analysis.
    Cleary SM; McIntyre D; Boulle AM
    Cost Eff Resour Alloc; 2006 Dec; 4():20. PubMed ID: 17147833
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Cost-Effectiveness Analysis of a Pediatric Operating Room in Uganda.
    Yap A; Muzira A; Cheung M; Healy J; Kakembo N; Kisa P; Cunningham D; Youngson G; Sekabira J; Yaesoubi R; Ozgediz D
    Surgery; 2018 Nov; 164(5):953-959. PubMed ID: 29801729
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The cost-effectiveness of screening for oral cancer in primary care.
    Speight PM; Palmer S; Moles DR; Downer MC; Smith DH; Henriksson M; Augustovski F
    Health Technol Assess; 2006 Apr; 10(14):1-144, iii-iv. PubMed ID: 16707071
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL; Figgitt DP
    Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cost-effectiveness of mandatory bicycle helmet use to prevent traumatic brain injuries and death.
    Reuvers R; Over EAB; Suijkerbuijk AWM; Polder JJ; de Wit GA; van Gils PF
    BMC Public Health; 2020 Mar; 20(1):413. PubMed ID: 32228524
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Systematic Review of Cost-Effectiveness Studies Reporting Cost-per-DALY Averted.
    Neumann PJ; Thorat T; Zhong Y; Anderson J; Farquhar M; Salem M; Sandberg E; Saret CJ; Wilkinson C; Cohen JT
    PLoS One; 2016; 11(12):e0168512. PubMed ID: 28005986
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cost-Effectiveness of Peer Counselling for the Promotion of Exclusive Breastfeeding in Uganda.
    Chola L; Fadnes LT; Engebretsen IM; Nkonki L; Nankabirwa V; Sommerfelt H; Tumwine JK; Tylleskar T; Robberstad B;
    PLoS One; 2015; 10(11):e0142718. PubMed ID: 26619338
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cost-effectiveness of maternal GBS immunization in low-income sub-Saharan Africa.
    Russell LB; Kim SY; Cosgriff B; Pentakota SR; Schrag SJ; Sobanjo-Ter Meulen A; Verani JR; Sinha A
    Vaccine; 2017 Dec; 35(49 Pt B):6905-6914. PubMed ID: 29129451
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cost-effectiveness of Canakinumab for Prevention of Recurrent Cardiovascular Events.
    Sehested TSG; Bjerre J; Ku S; Chang A; Jahansouz A; Owens DK; Hlatky MA; Goldhaber-Fiebert JD
    JAMA Cardiol; 2019 Feb; 4(2):128-135. PubMed ID: 30649147
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.